Tuesday Apr 15
Analysts View on Biotech Equities -- Research on Organovo Holdings,...
The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 648.05, up 0.51%, while the same has fallen by 1.86% in the previous three months.
Trending on the Topix Network
Tue Apr 08, 2014
Press release distribution, EDGAR filing, XBRL, regulatory filings
In first quarter 2014, ... )--Government Properties Income Trust today announced its regular quarterly common share distribution of $0.43 per common share .
View Press Release
If you own common stock in Spectrum Pharmaceuticals, Inc. and wish to obtain additional information, please contact Eduard Korsinsky, Esq.
Stock market live blog: S&P 500 breaks 3-day skid; Google, Yahoo, eBay rally
Rajesh C. Shrotriya, chairman and chief executive of Spectrum Pharmaceuticals, says with conviction that a lot of biotech shares are overvalued because, simply put, they've been "selling a dream" instead of focusing on fundamentals.
Mon Apr 07, 2014
Spectrum Pharmaceuticals Downgraded by TheStreet to "Sell"
The analysts wrote, "Spectrum Pharmaceuticals has been downgraded by TheStreet Ratings from hold to sell.
Tue Apr 01, 2014
Bangor Daily News
Varney Agency hires Lee Rossignol, director of sales
Varney Agency is pleased to announce the hiring of Lee Rossignol, director of sales.
Thu Mar 27, 2014
Topotarget announces financial results for the year ended Dec 31, 2013
A net loss in continued operations of ). Revenues are composed of milestone payments from the renegotiated agreement with Apricus Biosciences, Inc. and income per our collaboration agreement with Spectrum Pharmaceuticals.
Wed Mar 26, 2014
Topotarget confirms receipt of acceptance-to-file milestone payment
Topotarget A/S hereby confirms the receipt of the milestone payment of USD 10 million and 1 million shares from Spectrum Pharmaceuticals, Inc. related to the US Food and Drug Administration's recent acceptance to file BeleodaqTM for peripheral T-cell lymphoma .
Thu Mar 20, 2014
Teleconference regarding annual report 2013
Topotarget announces that a teleconference regarding the Company's annual report 2013 will be held on March 27, 2014 at 2:00 pm CET.
Wed Mar 19, 2014
Mountain View's Anacor Pharmaceuticals, Inc. Finds Its New CEO
Anacor Pharmaceuticals Appoints Paul L. Berns as Chief Executive Officer PALO ALTO, Calif.-- -- Anacor Pharmaceuticals, Inc. today announced that the Company's Board of Directors has appointed Paul L. Berns, Anacor's Chairman of the Board of Directors, to assume the role of President and Chief Executive Officer, effective immediately.